What are the common side effects of dasatinib?

Dasatinib (Dasatinib), sold under trade names such as Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Specifically, it is used to treat cases of Philadelphia chromosome positive (Ph+).

Common adverse reactions to dasatinib include low white blood cells, low platelets, anemia, swelling, rash, and diarrhea. Serious adverse reactions may include bleeding, pulmonary edema, heart failure, and prolonged QT syndrome. Using dasatinib during pregnancy may cause harm to the baby. Dasatinib is a tyrosine kinase inhibitor that works by blocking multiple tyrosine kinases, such as the Bcr-Abl and Src kinase families. When using dasatinib, patients must strictly follow the doctor's instructions and pay close attention to changes in their physical condition.

In general, although dasatinib has significant efficacy in the treatment of leukemia, its side effects cannot be ignored. Patients should remain vigilant during use and promptly report any discomfort or abnormal symptoms to their doctor.

Dasatinib is currently on the market in China, and dasatinib has been included in my country's Class B medical insurance reimbursement items. There are original research version and domestic generic version of dasatinib on the domestic market. The original version of dasatinib has a specification of 50*60 tablets. The price after reimbursement by medical insurance is around 5,000yuan. The domestic generic version is 50mg*7 tablets and the price is around 400yuan. It is understood that there are a variety of overseas imitation versions available in India and Bangladesh, with specifications of 50mg*60 and prices ranging from 600 to 1,000 yuan. The overseas imitation versions are more cost-effective than the domestic versions.